Liver Diseases: all 2,094 studies
Page 16 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Psychosocial Risks in Liver Transplant RecipientsCompletedNCT02826460
- Nutritional Assessment Tool in Childhood Chronic Liver DiseaseCompletedNCT02802761
- Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic HepatitisCompletedNCT02796469
- A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With ObesityCompletedNCT02787668Not applicable
- Non-invasive Liver Screening for Risk Assessment for Coronary Heart DiseaseCompletedNCT02779946
- Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the NeonatesStatus unknownNCT02764671Phase 4
- Probiotics in the Treatment of NAFLDStatus unknownNCT02764047Not applicable
- Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)Status unknownNCT02758977Not applicable
- Half-life of Plasma Phytosterols in Preterm Infants on Parenteral NutritionCompletedNCT02758834
- Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic DysfunctionCompletedNCT02754219Phase 1
- Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT02728765Not applicable
- NASH: Non-invasive Diagnostic Markers and ImagingStatus unknownNCT02717000
- Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk FactorsStatus unknownNCT02716870
- Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver DiseaseCompletedNCT02715973Not applicable
- Minocycline Administration During Human Liver TransplantationWithdrawnNCT02712775Phase 4
- Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver ResectionTerminatedNCT02710266Phase 3
- Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic RiskStatus unknownNCT02702479
- SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitisCompletedNCT02696941Phase 1
- Lifestyle Intervention For Liver TransplantationStatus unknownNCT02696655Not applicable
- PK Study of T-817 in Subjects With Hepatic ImpairmentCompletedNCT02693197Phase 1
- Effect of Vitamin E on Non-Alcoholic Fatty Liver DiseaseCompletedNCT02690792Not applicable
- Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) FibrosisCompletedNCT02686762Phase 2
- Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 DiabetesCompletedNCT02686476Not applicable
- Is Eovist Suitable for Arterial-Phase MR Imaging of LiverCompletedNCT02684526Not applicable
- Magnetic Resonance Imaging (MRI) Fat Quantification of the LiverCompletedNCT02682173Not applicable
- The Effects of Type of Exercise in Non-alcoholic Fatty Liver DiseaseCompletedNCT02679417Not applicable
- Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseWithdrawnNCT02658786
- Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian AdultsStatus unknownNCT02654665Phase 3
- Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPGStatus unknownNCT02653846
- Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative StressCompletedNCT02650830
- Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples (MICRONACH)CompletedNCT02650115
- Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver DiseaseSuspendedNCT02650011
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDCompletedNCT02649465Phase 4
- To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With AscitesCompletedNCT02649335Phase 3
- Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT02649049
- Spinal Versus Epidural Analgesia in Laparotomic Liver SurgeryStatus unknownNCT02647047Not applicable
- Impact of Ketogenic Diet on Lipoproteins in Refractory EpilepsyStatus unknownNCT02644239Not applicable
- Prebiotics in Patients With Non-alcoholic Liver DiseaseCompletedNCT02642172Not applicable
- Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 DiabetesCompletedNCT02637973Phase 4
- Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, CambodiaTerminatedNCT02628691
- Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.CompletedNCT02624557Phase 1
- Hepatic Venous Pressure Gradient and Platelet Activation in Chronic Liver DiseaseStatus unknownNCT02618798
- Spray Diathermy Versus Harmonic Scalpel Technique for Hepatic Parenchymal TransectionCompletedNCT02617498Early Phase 1
- A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineCompletedNCT02611505Phase 1
- Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic FunctionCompletedNCT02604498Phase 1
- Serine Supplementation for Obese Subjects With Fatty Liver DiseaseCompletedNCT02599038Phase 1/2
- Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After TransplantationCompletedNCT02584283Phase 3
- Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic ImpairmentCompletedNCT02581592Phase 1
- Quantifying Steatosis in Liver Transplant DonorsActive, not recruitingNCT02579408
- A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215CompletedNCT02571816Phase 1
- The Effect of an RBAC Supplement (BRM4) on NAFLDCompletedNCT02568787Not applicable
- Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver DiseaseCompletedNCT02568605Not applicable
- Transforming Non-Invasive Liver Disease Detection by MRE: The HepatogramCompletedNCT02565446Not applicable
- Resolution of Liver Fat in Non-alcoholic Fatty Liver DiseaseCompletedNCT02558530Not applicable
- Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver ResectionTerminatedNCT02555293Phase 2
- Impact of MELD Score for 1000 Consecutive Liver TransplantationsCompletedNCT02548130
- Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and SteatosisStatus unknownNCT02542020
- Using Covered Stent of Diameter of 7mm in TIPSStatus unknownNCT02541825Phase 1
- Effect of Ginger Supplement on Non-alcoholic Fatty LiverCompletedNCT02535195Phase 2/3
- Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic HepatectomyCompletedNCT02533193Not applicable
- Non-invasive Evaluation of Portal Pressure by MRITerminatedNCT02530567Not applicable
- Hepatic Inflammation and Physical Performance in Patients With NASHCompletedNCT02526732Not applicable
- A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic FunctionCompletedNCT02524717Phase 1
- Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT02520609
- Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver DiseasesCompletedNCT02517385Phase 3
- Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in AndalusiaStatus unknownNCT02511496
- Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart DiseaseCompletedNCT02506335Early Phase 1
- A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver TransplantationCompletedNCT02504138Phase 4
- A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver DiseaseTerminatedNCT02503683Phase 1
- Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative PatientsTerminatedNCT02499185Phase 4
- Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLDCompletedNCT02496390Phase 1/2
- Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease PatientsCompletedNCT02491905Phase 2
- "Hepafast" in Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02491229Not applicable
- Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT02488941
- Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for TransplantationStatus unknownNCT02478151Phase 1
- Compassionate Use of Omegaven IV Fat EmulsionNo longer availableNCT02477345
- INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic FunctionCompletedNCT02474537Phase 1
- Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver CirrhosisStatus unknownNCT02473601Phase 2
- PK Study of Sotagliflozin in Subjects With Hepatic ImpairmentCompletedNCT02471274Phase 1
- Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot StudyStatus unknownNCT02469272Phase 1
- Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in YouthCompletedNCT02461212Not applicable
- Mitochondrial Function in Patients With Severe Liver DiseaseTerminatedNCT02457702Not applicable
- Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot StudyWithdrawnNCT02457286Phase 1
- Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT02452801Phase 1
- Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver DiseaseStatus unknownNCT02452177Not applicable
- The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish HospitalCompletedNCT02444273Not applicable
- Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related QualityCompletedNCT02427204
- Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical ActivityCompletedNCT02427087Not applicable
- A Pharmacokinetic and Safety Study of E7080 in Subjects With Mild (10 mg), Moderate (10 mg), and Severe Hepatic Impairment (5 mg) and Normal Hepatic Function (10 mg)CompletedNCT02421042Phase 1
- Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in InfantsWithdrawnNCT02420496Phase 2
- Short Term Intermittent Fasting and Insulin ResistanceStatus unknownNCT02420054Not applicable
- Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver ResectionCompletedNCT02414880Phase 4
- Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASHCompletedNCT02412540Not applicable
- Protein-rich Diet and NAFLD in Bariatric SurgeryStatus unknownNCT02400099Not applicable
- The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT02395900Phase 2/3
- Fatty Liver Disease Collaborative Research in ChinaStatus unknownNCT02391168
- Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASHCompletedNCT02390232
- Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in ChildrenCompletedNCT02383485Not applicable
- Copenhagen Comorbidity in HIV Infection StudyActive, not recruitingNCT02382822
- THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.CompletedNCT02381769Not applicable